Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of FAPI Imaging for the Prediction of Adverse Cardiovascular Events in Chronic Total Occlusion of Coronary Artery Disease (FACT-2 Trial)

NCT07020858 is registered in ClinicalTrials.gov with Lin Zhao as lead sponsor.

NCT NCT07020858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of FAPI Imaging for the Prediction of Adverse Cardiovascular Events in Chronic Total Occlusion of Coronary Artery Disease (FACT-2 Trial)
Lead sponsor
Lin Zhao
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2025
Completion date
March 15, 2027
Enrollment
470 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic coronary syndrome, chronic total occlusion (cto)